Menu
Not yet recruiting NCT07220174

Use of GI Genius™ XR Software in Virtual Reality Headset During Routine Colonoscopy

No phase Interventional Colonoscopy (Procedure)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: software GI Genius™ XR on headset.
Who it may be relevant to
Registry conditions: Colonoscopy (Procedure). Basic parameters: from 45 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Pilot Usability Evaluation of GI Genius™ XR Software Running on a Virtual Reality Headset During Routine CRC Screening and Surveillance Colonoscopies

Overview

This pilot study will evaluate the usability and safety of software GI Genius™ XR in the Apple Vision Pro™ virtual reality headset when used in conjunction with the GI Genius™ system during routine screening and surveillance colonoscopy procedures. GI Genius™ XR enables colonoscopists to view the standard live endoscopic video feed within a virtual reality environment as an alternative to the conventional endoscopy tower display. The system provides a virtual screen that mirrors the tower video output without any image analysis or interpretation, allowing users to adjust screen size and position for optimal visualization and situational awareness.

Interventions

  • Device software GI Genius™ XR on headset
    The screening or surveillance colonoscopy is performed with the endoscopist wearing the headset and using the software GI Genius™ XR.

Primary outcome measures

  • Adverse events [Time frame: Day 1]
  • GI Genius™ XR critical tasks [Time frame: Day 1]
  • Use effects [Time frame: Day 1]
  • Problem resolution process [Time frame: Day 1]
  • Time management [Time frame: During the procedure]
  • Interruption management [Time frame: Day 1]
  • User feedback on usability [Time frame: Day 1]
Secondary outcome measures (1)
  • System Usability Score [Time frame: Through study completion, an average of 3 months]

Eligibility criteria

Inclusion Criteria for patient:

  • Male or female aged ≥ 45 years;
  • Scheduled for routine CRC screening or surveillance colonoscopy;
  • Written informed consent to participate.

Inclusion Criteria for endoscopist:

  • Male or female board-certified gastroenterologists experienced with CRC screening and surveillance colonoscopy;
  • Written informed consent to participate.

Exclusion Criteria for patient:

  • Not able to comply with the protocol requirement;
  • Implanted or worn medical device (pacemaker, defibrillator, insulin pump, etc.).

Exclusion Criteria for endoscopist:

  • Not able to comply with the protocol requirement;
  • Implanted or worn medical device (pacemaker, defibrillator, insulin pump, etc.);
  • Risk of falls;
  • Seizures;
  • Heart disease;
  • Pregnant;
  • Migraines;
  • Eye or vision disorder;
  • Inner ear disorder;
  • Psychological disorder.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

United States · 1 center
  • Rush University Medical Center — Chicago

Identifiers

NCT: NCT07220174 · CB-30-08/01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗